NEW YORK (GenomeWeb News) – Veracyte said after the close of the market on Tuesday that revenues for its fourth quarter rose 51 percent year over year.

The South San Francisco, Calif.-based firm recorded $6.8 million in revenues for the three months ended Dec. 31, 2013, up from $4.5 million in the year-ago fourth quarter. In a statement, Veracyte President and CEO Bonnie Anderson said, "We saw increases in fine needle aspiration sample volumes and cash collections during the fourth quarter, which is traditionally our strongest quarter."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.